Skip to main content
SpringerLink
Log in

Evidence that hypophagia induced bymCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Male Sprague-Dawley rats deprived of food for 18 h were injected with the 5-HT agonists RU 24969, 1-(3-chlorophenyl)piperazine (mCPP) or 1-[3-(trifluoromethyl)phenyl)]piperazine (TFMPP) and 20 min later presented with their normal diet. Food intake was determined 1, 2 and 4 h later. All three drugs reduced intake over 1 and 2 h. Three out of four drugs with high affinity for 5-HT1C receptors (metergoline, mianserin, and mesulergine but not cyproheptadine) opposed hypophagia caused bymCPP. Another drug reported to have high affinity for the 5-HT1C site, 1-naphthyl-piperazine (1-NP), also blocked the hypophagic response tomCPP at doses which attenuatedmCPP-induced hypolocomotion. Only one of the above drugs (metergoline) which also has high affinity for other 5-HT sites opposed hypophagia caused by RU 24969. Two out of three 5-HT1B receptor antagonists [(±) cyanopindolol, (−) propranolol, but not (−) pindolol)] which oppose hypophagia caused by RU 24969 (Kennett et al. 1987) also opposed hypophagia caused bymCPP. The 5-HT2 antagonists ketanserin and ritanserin, the 5-HT3 antagonist ICS 205-930 and the α2 adrenoceptor antagonist idazoxan did not oppose the hypophagic effect ofmCPP. In agreement with results formCPP, hypophagia caused by TFMPP was opposed by both, mianserin and (±) cyanopindolol. Given alone, mianserin 1-NP and cyproheptadine but not ICS 205-930 increased food consumption of normally fed rats. The results suggest that RU 24969-induced hypophagia depends on 5-HT1B receptors but not on 5-HT1C receptors, whilemCPP (and TFMPP)-induced hypophagia may depend on both receptors. Thus, 5-HT1C and 5-HT1B receptors may evoke hypophagia via a common pathway but the effect of antagonists implies that at the doses usedmCPP and TFMPP act predominantly at 5-HT1C receptors. Since only the hypophagic response tomCPP is blocked by cyanopindolol and (−) propranolol (Kennett and Curzon 1988) it is unlikely to be secondary to hypoactivity induced by the drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Asarch KE, Ransom RW, Shih JS (1985) 5-HT1A and 5-HT1B selectivity of two phenylpiperazine derivatives: evidence for 5-HT1B heterogeneity. Life Sci 36:1265–1273

    Article  PubMed  CAS  Google Scholar 

  • Baxter MJ, Miller AA, Soroko FE (1970) The effect of cyproheptadine on food consumption in the fasted rat. Br J Pharmacol 39:229–230

    Google Scholar 

  • Bergen SS (1964) Appetite stimulating properties of cyproheptadime. Am J Dis Child 108:270–273

    PubMed  Google Scholar 

  • Clineschmidt BV, Flataker LM, Faison E, Holmes R (1979) An in vivo model for investigation α1 and α2-receptors in the CNS: studies with mianserin. Arch Int Pharmacodyn 242:59–76

    PubMed  CAS  Google Scholar 

  • Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1C) receptors. J Pharmacol Exp Ther 242:552–557

    PubMed  CAS  Google Scholar 

  • Closse A (1983) [3H] mesulergine, a selective ligand for serotonin-2 receptors. Life Sci 32:2485–2495

    Article  PubMed  CAS  Google Scholar 

  • Dickinson SL, Gadie B, Tulloch IF (1987) Preclinical in vivo assessment of α2 adrenergic activity in the central nervous system. Proc 1st Int Symp on Preclin Strategies in Psychopharmacol, Paris, p 6

  • Dourish CT, Hutson PH, Curzon G (1985) Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Brain Res Bull 15:377–384

    Article  PubMed  CAS  Google Scholar 

  • Dourish CT, Hutson PH, Kennett GA, Curzon G (1986) 8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance. Appetite [Suppl] 7:127–140

    PubMed  CAS  Google Scholar 

  • Engel G, Gothert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332:1–7

    Article  CAS  Google Scholar 

  • Ferguson JJ, Feighner JP (1987) Fluoxetine induced weight loss in non-depressed overweight humans. Am J Psychiatry 143:1496

    Google Scholar 

  • Fuller RW, Mason NR, Snoddy HD, Perry KW (1986) 1-(1-naphthyl)piperazine, a central serotonin agonist. Res Commun Chem Pathol Pharmacol 51:37–45

    PubMed  CAS  Google Scholar 

  • Ghosh MN, Parvathy S (1973) The effect of cyproheptadine on water and food intake and on body weight in the fasted adult and weanling rats. Br J Pharmacol 48:328–329

    Google Scholar 

  • Goudie AJ, Thornton EW, Wheeler TJ (1978) Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for a serotonergic inhibition of feeding. J Pharm Pharmacol 28:318–320

    Google Scholar 

  • Green AR, Guy AP, Gardner CR (1984) The behavioural effects of RU 24969, a suggested 5-HT, receptor agonist in rodents and the effect on the behaviour of treatment with antidepressants. Neuropharmacology 23:655–661

    Article  PubMed  CAS  Google Scholar 

  • Hamon M, Cossery J-M, Spampinato U, Gozlan H (1986) Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in brain? TIPS 7:336–337

    CAS  Google Scholar 

  • Harris B, Harper M (1980) Unusual appetites in patients on mianserin. Lancet I:590

    Article  Google Scholar 

  • Heuring RE, Peroutka SJ (1987) Charaterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J Neurosci 7:894–903

    PubMed  CAS  Google Scholar 

  • Hopman H (1980) Mianserin in out patients with depressive illness in dosage up to 130 mg daily. Curr Med Res Opin [Suppl 7] 6:107–114

    Google Scholar 

  • Hoyer D (1988) Biochemical mechanisms of 5-HT receptor effector coupling in peripheral tissues. In: Fozard J (ed) Peripheral actions of 5-HT. Oxford University Press (in press)

  • Hoyer D, Engel G, Kackman HO (1985) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H] 5-HT, [3H] 8-OH-DPAT, (−) [125I] iodocyanopindolol, [3H] mesulergine and [3H] ketanserin. Eur J Pharmacol 118:13–23

    Article  PubMed  CAS  Google Scholar 

  • Hutson PH, Donohoe TP, Curzon G (1988) Infusion of the 5-hydroxytryptamine agonists RU 24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology 95:550–552

    Article  PubMed  CAS  Google Scholar 

  • Hutson PH, Dourish CT, Curzon G (1986) Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by cell body autorcceptors. Eur J Pharmacol 129:347–352

    Article  PubMed  CAS  Google Scholar 

  • Invernizzi R, Cotecchia S, De Blasi A, Mennini T, Pataccini R, Samanin R (1981) Effects ofm-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats. Neurochem Int 3:239–244

    Article  CAS  Google Scholar 

  • Kennett GA, Curzon G (1988) Evidence thatmCPP may have behavioural effects mediated by 5-HT1C receptors. Br J Pharmacol 94:137–147

    PubMed  CAS  Google Scholar 

  • Kennett GA, Dourish CT, Curzon G (1987) 5-HT1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol 141:429–435

    Article  PubMed  CAS  Google Scholar 

  • Kilpatrick GJ, Jones BJ, Tyers MB (1988) Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330:746–748

    Article  Google Scholar 

  • Lavenstein AF, Lasagna L, Van Metre TE (1962) Effect of cyproheptadine on asthmatic children, study of appetite, weight gain and linear growth. JAMA 180:912–916

    PubMed  CAS  Google Scholar 

  • Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PAJ (1981) Receptor binding profile of R41 468, a novel antagonist of 5-HT2 receptors. Life Sci 28:1015–1022

    Article  PubMed  CAS  Google Scholar 

  • Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PAJ, Laduron PM (1985) Receptor binding properties in vitro and in vivo of ritanserin, a very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27:600–611

    PubMed  CAS  Google Scholar 

  • Lucki I, Frazer A (1982) Behavioural effects of indole and piperazine type serotonin receptor agonists. Soc Neurosci Abst 8:101

    Google Scholar 

  • Menon MK, Clark WG, Aures D (1971) Effect of Thiazol-4-xylmethoxyamine, a new inhibitor of histamine biosynthesis on brain histamine, monoamine levels and behaviour. Life Sci 10:1097–1109

    Article  CAS  Google Scholar 

  • Peng Y, Tews JK, Harper AE (1972) Amino acid imbalance, protein intake, and changes in rat brain and plasma amino acids. Am J Physiol 222:314–321

    PubMed  CAS  Google Scholar 

  • Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS (1975) Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 10:241–323

    PubMed  CAS  Google Scholar 

  • Pinder RM, Blum A, Stulemeijer SM, Barres M, Molczadzki M, Rigand A, Charbaut J, Israel L, Kammerer T (1980) A double-blind multi-centre trial comparing the efficacy and side effects of mianserin and clomipramine is depressed in-patients and out patients. Curr Med Res Opin [Suppl 7] 6:115–122

    Google Scholar 

  • Richardson BP, Engel S, Donatsch P, Stadler PA (1985) Identification of serotoninm-receptor subtypes and their specific blockade by a new class of drugs. Nature 316:126–131

    Article  PubMed  CAS  Google Scholar 

  • Rowland NC, Carlton J (1986) Neurobiology of an anorexic drug fenfluramine. Prog Neurobiol 27:13–62

    Article  PubMed  CAS  Google Scholar 

  • Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S (1979)m-chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg's Arch Pharmacol 308:159–163

    Article  CAS  Google Scholar 

  • Sills MA, Wolfe BB, Frazer A (1984) Determination of selective and non-selective compounds for the 5-HT1A and 5-HT1B receptor subtypes in rat frontal cortex. J Pharmacol Exp Ther 231:480–487

    PubMed  CAS  Google Scholar 

  • Smith TM, Suckow RF (1985) Trazodone andm-chlorophenylpiperazine; concentration in brain and receptor activity in regions in the brain associated with anxiety. Neuropharmacology 24:1067–1071

    Article  PubMed  CAS  Google Scholar 

  • Tricklebank MD, Middlemiss DN, Neill J (1986) Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist RU 24969 in the rat. Neuropharmacology 25:877–886

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurochemistry, Institute of Neurology, Queen Square, WC1N 3BG, London, UK

    G. A. Kennett & G. Curzon

Authors
  1. G. A. Kennett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Curzon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kennett, G.A., Curzon, G. Evidence that hypophagia induced bymCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology 96, 93–100 (1988). https://doi.org/10.1007/BF02431539

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02431539

Key words

Search

Navigation